Forodesine hydrochloride
Key facts
| Active substance |
Forodesine hydrochloride
|
| Therapeutic area |
Oncology
|
| Decision number |
P/69/2010
|
| PIP number |
Forodesine hydrochloride
|
| Pharmaceutical form(s) |
Capsule, hard
|
| Condition(s) / indication(s) |
Treatment of Cutaneous T-Cell Lymphoma
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Mundipharma Research Ltd
E-mail: paediatric@mundipharma-rd.eu |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|